阿石創(300706.SZ):異質電池用ITO靶材目前已在部分客户中進行驗證
格隆匯5月17日丨阿石創(300706.SZ)於2023年5月15日下午16:00-17:30召開業績説明會,問答環節中,就“阿石創是一採用的是訂單生產,在營業額增長的情況下為什麼還用出現虧損。在2022年報中提到今年公司發展的重要2個方面推廣異質電池用ITO靶材,複合銅箔項目這兩方面的進展如何”,公司回覆稱,2022年公司營收保持增長,淨利潤有所下降,一方面2022年主要下游客户所屬行業如3C、面板等稼動率下修,市場競爭增加;另一方面,公司子公司取得高新企業認證,企業所得税有所增加。
異質電池用ITO靶材目前已在部分客户中進行驗證,複合銅箔項目設備已進入設備交付與安裝環節,兩個項目的具體進度請您留意公司後期對外披露的相關信息。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.